ight on glaucoma: pilot study
- Conditions
- Glaucoma
- Registration Number
- NL-OMON22600
- Lead Sponsor
- nversity Medical Center Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
Healthy subjects will consist of people (age 18-70) who have signed in, without ophthalmic abnormalities and provide written informed consent.
Exclusion Criteria
- Subjects with an eye disease.
- Subjects with a first degree relative with glaucoma, or with high eye pressure in the past.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measurement of contrast sensitivity, visual field and adaptation time at high light conditions.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie contrast sensitivity changes in glaucoma patients under high light conditions?
How do visual field measurements in observational glaucoma studies compare with standard invasive treatment outcomes?
Are there specific biomarkers that correlate with adaptation time improvements in high intraocular pressure glaucoma subtypes?
What adverse events are associated with non-invasive glaucoma monitoring techniques involving contrast sensitivity testing?
How effective are combination therapies involving prostaglandin analogs and visual field adaptation strategies in managing glaucoma progression?